Effects of 0.1% Nepafenac on Vitreous Inflammatory Biomarkers in Rhegmatogenous Retinal Detachment and Proliferative Vitreoretinopathy
NCT07162818
Eye Diseases, Proliferative Vitreoretinopathy
Jakarta, Jakarta Pusat, Indonesia
View Trial DetailsNCT Number: NCT01446367
The purpose of this study is to evaluate the corneal changes after performing 20 gauge vitrectomy associated with scleral buckling for the treatment of rhegmatogenous retinal detachment.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Observational
Patients submitted to 20-gauge vitrectomy associated with scleral buckling were evaluated with corneal topography before surgery and in the 7,30 and 90 days after surgery to asses corneal curvature changes.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Universidade Federal do Paraná
Other
Corneal Topographic Changes After 20-gauge Pars Plana Vitrectomy Associated With Scleral Buckling for the Treatment of Rhegmatogenous Retinal Detachment
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07162818
Eye Diseases, Proliferative Vitreoretinopathy
Jakarta, Jakarta Pusat, Indonesia
View Trial DetailsNCT06919211
Rhegmatogenous Retinal Detachment
Cairo, Egypt
View Trial DetailsNCT04891991
Eye Diseases, Proliferative Vitreoretinopathy
Cairo, Egypt
View Trial DetailsNCT05377606
Primary Vitrectomy, Rhegmatogenous Retinal Detachment
Cairo, Egypt
View Trial Details